EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Case of Pegfilgrastim‐Induced Sweet Syndrome and Literature Review of Similar Cases

Meghana Kesireddy, Olivia L. Makos, Dominick J. DiMaio, Jairam Krishnamurthy

Case Reports in Oncological Medicine · 2026-01 · 2026 (1)

DOI: 10.1155/crom/1759090 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Case Reports in Oncological Medicine, online erschienen am 17.03.2026. Verfasst von Meghana Kesireddy und 3 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sweet′s syndrome (SS), also known as acute febrile neutrophilic dermatosis, is a rare disorder characterized by painful erythematous lesions, fever, and neutrophilic dermal infiltrates. Drug‐induced Sweet′s syndrome (DISS) is most often associated with short‐acting granulocyte colony‐stimulating factors (G‐CSF), whereas pegfilgrastim, the long‐acting form, is only rarely implicated, with just eight prior cases reported. We describe a 50‐year‐old woman with breast cancer who developed fever and painful plaques within days of pegfilgrastim administration during adjuvant chemotherapy. Infectious studies were negative, and a biopsy confirmed histiocytoid SS. Corticosteroid therapy led to rapid defervescence and lesion resolution, and chemotherapy was completed without further G‐CSF support. Including this case, only nine patients with pegfilgrastim‐related DISS have been reported. Most were women under 60 receiving chemotherapy for breast or hematologic malignancies. Symptoms developed 3–11 days after the first dose, with consistent resolution following pegfilgrastim withdrawal and corticosteroid therapy. Notably, some patients tolerated short‐acting G‐CSF without recurrence, suggesting pharmacokinetic differences may explain the association. Pegfilgrastim‐induced DISS is exceedingly rare but important to recognize. Prompt diagnosis can prevent unnecessary antimicrobial use, ensure timely corticosteroid treatment, and guide safe supportive care in oncology patients.

Zitieren

APA

Kesireddy, M., Makos, O. L., DiMaio, D. J., & Krishnamurthy, J. (2026). A Case of Pegfilgrastim‐Induced Sweet Syndrome and Literature Review of Similar Cases. Case Reports in Oncological Medicine, 2026(1). https://doi.org/10.1155/crom/1759090

Vancouver

Kesireddy M, Makos OL, DiMaio DJ, Krishnamurthy J. A Case of Pegfilgrastim‐Induced Sweet Syndrome and Literature Review of Similar Cases. Case Reports in Oncological Medicine. 2026;2026(1). doi:10.1155/crom/1759090

BibTeX
@article{Kesireddy2026,
  author = {Kesireddy, Meghana and Makos, Olivia L. and DiMaio, Dominick J. and Krishnamurthy, Jairam},
  title = {A Case of Pegfilgrastim‐Induced Sweet Syndrome and Literature Review of Similar Cases},
  journal = {Case Reports in Oncological Medicine},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/crom/1759090}
}
Kostenlos starten →